Andy Watson

Background

About Andy Watson

Senior executive with verifiable year-after-year success achieving revenue, profit, product launch, and business growth objectives in start-up, small and large company environments. • Successful Products: Extensive experience conceptualizing and commercializing integrated instrument-consumable-assay products, creating significant value in research, translational, CAP/CLIA, and regulated markets. • Driven and creative: A passion for commercial success through the integration of technology teams, differentiated products, launch strategy and customer needs. • Team builder and leader: Built and motivated global sales & field support, corporate marketing, product management, business development, engineering, bio-informatics and assay teams. • Business management: Managed high growth (>300%) and mature businesses (>$500 million annual revenue). Managed products from concept to launch to life cycle management. • Alliances and M&A: Sourced, nurtured, negotiated and managed strategic alliances with multi-national corporations, university labs, and commercial service organizations. Raised over $140 million from corporate partnerships, venture capital, debt, and government grants. Key player in M&A with deals up to $725 million. • Accomplished technologist: 16 patents and 10 peer-reviewed publications in next generation sequencing, hand-held diagnostic testing, digital PCR, microfluidics, and others. Author on seminal human genome and C. Elegans sequencing papers. Principal Investigator on several large grants and NIH reviewer.